For quantitative analysis of DHE oxidation products, HPLC electrochemical analysis was performed [3, 4] . Briefly, 8226 cells (1×10 6 cells/condition) were preloaded with DHE (10 μM at 37
• C for 30 min), followed by treatment with IL-6 (50 ng/ml) or antimycin A (10 μM), or no treatment (control) for 30 min. Cells were centrifuged, washed with PBS, counted and stored at − 80
• C. On the day of HPLC analysis, samples were prepared as described by Zielonka et al. [3] . An ESA CoulArray system with a Phenomenex 250 mm×4.6 mm Synergi 4 μm Polar-RP 80A column was used to quantify oxidation products of DHE. MM.1S cells were treated for 0.5, 1 or 2 h with (A) IL-6 or (B) IR, and DHE oxidation was measured by flow cytometry. Graphs with MFI values are shown from one experiment, and are representative of two experiments. (C) Myeloma cells were pretreated without or with NAC, and then incubated with IL-6 (1, 2.5, 10 or 50 ng/ml) and H 2 DCF-DA oxidation was measured at 2 h. *P < 0.05 compared with control (no IL-6 treatment).
Quantification of 2-OH-E
+ was determined using the 200, 280 and 365 mV channels, and E + , using the 280, 365, 400, 450 and 500 mV channels and standard curves were prepared from authentic standards. HPLC data were adjusted for cell numbers and dilutions made during sample processing and analysis.
NF-κB assay
The transcriptional activity of NF-κB was measured using an ELISA-based assay (TransAM NF-κB p65 transcription factor assay kit) as described previously [5] . Cells were infected with or without Ad-IκBα-DN for 48 h and exposed to 6-Gy IR or sham IR. Nuclear extracts were prepared 2 h after IR and incubated with immobilized oligonucleotide containing a consensus-binding site for the p65 subunit of NF-κB or the control oligonucleotide. Binding was detected by a primary antibody specific for p65 followed by incubation with anti-IgG antibody conjugated to horseradish peroxidase. The product was quantified at 450 nm. Absorbance of the untreated cells was set to 1 and the fold activation/repression in the NF-κB activity was evaluated after normalizing the samples for cellular protein content.
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Figure S2 2-OH-E
+ , the superoxide-derived oxidation product of DHE, is observed with HPLC Representative HPLC chromatograms from 8226 cells incubated with DHE and then treated with antimycin A (Ant A) or untreated (control; Cont) for an additional 30 min. For simplicity, one channel (365 mV) of the eight channels monitored is presented to illustrate retention times and relative intensities of the various oxidation products of DHE found in cell extracts. HE is dihydroethidine, 2-OH-E + is the O 2 • − -specific 2-hydroxyethidium product, and E + is the non-specific two-electron oxidation product, ethidium. HPLC with electrochemical detection was performed using an ESA CoulArray system with a Phenomenex 250 mm×4.6 mm Synergi 4 μm Polar-RP 80A column. Quantification of 2-OH-E + was determined using the 200, 280 and 365 mV channels, and E + was determined using the 280, 365, 400, 450 and 500 mV channels, and standard curves were prepared from authentic standards. The Table ( MM.1S and 8226 cells were treated with (A) IL-6 (2.5 or 10 ng/ml) and whole-cell extract was probed for MnSOD expression at 24 h. The ratio between MnSOD and tubulin levels, after normalization to untreated control, is shown above each band. Myeloma cells were treated with IL-6 (50 ng/ml) and/or IR (B) after pretreatment without or with NBD (50 μM for 2 h). Luc activity was measured at 4 h. Values are depicted as the fold change in mean RLU + − S.D., n = 3, normalized to protein concentration. *P < 0.01 compared with IL-6, P < 0.01 compared with IR treatment alone or IL-6 plus IR. Myeloma cells were treated with IL-6 (50 ng/ml) and/or IR (C) after 48 h of transduction with Ad-IκBα-DN (MOI = 10). The DNA-binding activity of NF-κB was analysed at 2 h in nuclear extracts. The results are presented as the fold repression or activation of NF-κB activity compared with control. *P < 0.01 and P < 0.01 compared with IR treatment alone. (D) Myeloma cells were transduced with Ad-IκBα-DN (MOI = 10), whole-cell extract was made at 48 h and probed with an antibody against IκBα or tubulin.
